From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...
Beyond R&D, AI is transforming the way biopharma companies commercialise therapies and interact with healthcare providers and patients. In a marketplace increasingly driven by personalised experiences ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
It helps journalists verify hypotheses, reveal hidden insights, follow the money, scale investigations, and add credibility ...
According to Precedence Research, the global kidney stone management market size will grow from USD 2.67 billion in 2025 to ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Apps are a fundamental part of modern technology. And if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results